Search research articles
Contact Us
Filters
Showing results (41-50 of 107) with videos related to
Page
of 11
Sort By:
Jac-Antimicrobial Resistance
|
November 15, 2024
State of the art of real-life concentration monitoring of rifampicin and its implementation contextualized in resource-limited settings: the Tanzanian case
Yuan J Petermann, Bibie Said, Annie E Cathignol, et al.
Pharmacological Research
|
May 21, 2019
Optimisation of vancomycin exposure in neonates based on the best level of evidence
Kim Dao, Monia Guidi, Pascal André, et al.
Clinical Pharmacokinetics
|
May 2, 2026
Evaluating Bayesian Vancomycin Dosage Adjustment in Neonates: A Simulation-Based Virtual TDM Study
Anne Ravix, Yann Thoma, Annie Cathignol, et al.
British Journal of Clinical Pharmacology
|
August 16, 2012
Prediction of free imatinib concentrations based on total plasma concentrations in patients with gastrointestinal stromal tumours
Amina Haouala, Nicolas Widmer, Monia Guidi, et al.
Clinical Pharmacokinetics
|
January 11, 2025
Improving Understanding of Fexofenadine Pharmacokinetics to Assess Pgp Phenotypic Activity in Older Adult Patients Using Population Pharmacokinetic Modeling
Frédéric Gaspar, Celestin Jacost-Descombes, Pauline Gosselin, et al.
European Journal of Clinical Pharmacology
|
January 16, 2021
Population pharmacokinetic modelling to quantify the magnitude of drug-drug interactions between amlodipine and antiretroviral drugs
Perrine Courlet, Monia Guidi, Susana Alves Saldanha, et al.
JMIR Research Protocols
|
October 21, 2024
Toward a Clinical Decision Support System for Monitoring Therapeutic Antituberculosis Medical Drugs in Tanzania (Project TuberXpert): Protocol for an Algorithm' Development and Implementation
Yann Thoma, Annie E Cathignol, Yuan J Pétermann, et al.
Therapeutic Drug Monitoring
|
March 19, 2013
Relationship of CYP2D6, CYP3A, POR, and ABCB1 genotypes with galantamine plasma concentrations
Muriel Noetzli, Monia Guidi, Karsten Ebbing, et al.
Pharmaceutics
|
April 28, 2023
Precision Oncology by Point-of-Care Therapeutic Drug Monitoring and Dosage Adjustment of Conventional Cytotoxic Chemotherapies: A Perspective
Myriam Briki, Pascal André, Yann Thoma, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
January 16, 2026
Pharmacometric-Based Evaluation of Salmeterol and Its Metabolite α-Hydroxysalmeterol in Plasma and Urine: Practical Implications for Doping Control
Paul Thoueille, Anne Danion, Morten Hostrup, et al.
Page
of 11
Search research articles
Search
Showing results (41-50 of 107) with videos related to
Sort By:
Page
of 11
Jac-Antimicrobial Resistance
|
November 15, 2024
State of the art of real-life concentration monitoring of rifampicin and its implementation contextualized in resource-limited settings: the Tanzanian case
Yuan J Petermann, Bibie Said, Annie E Cathignol, et al.
Pharmacological Research
|
May 21, 2019
Optimisation of vancomycin exposure in neonates based on the best level of evidence
Kim Dao, Monia Guidi, Pascal André, et al.
Clinical Pharmacokinetics
|
May 2, 2026
Evaluating Bayesian Vancomycin Dosage Adjustment in Neonates: A Simulation-Based Virtual TDM Study
Anne Ravix, Yann Thoma, Annie Cathignol, et al.
British Journal of Clinical Pharmacology
|
August 16, 2012
Prediction of free imatinib concentrations based on total plasma concentrations in patients with gastrointestinal stromal tumours
Amina Haouala, Nicolas Widmer, Monia Guidi, et al.
Clinical Pharmacokinetics
|
January 11, 2025
Improving Understanding of Fexofenadine Pharmacokinetics to Assess Pgp Phenotypic Activity in Older Adult Patients Using Population Pharmacokinetic Modeling
Frédéric Gaspar, Celestin Jacost-Descombes, Pauline Gosselin, et al.
European Journal of Clinical Pharmacology
|
January 16, 2021
Population pharmacokinetic modelling to quantify the magnitude of drug-drug interactions between amlodipine and antiretroviral drugs
Perrine Courlet, Monia Guidi, Susana Alves Saldanha, et al.
JMIR Research Protocols
|
October 21, 2024
Toward a Clinical Decision Support System for Monitoring Therapeutic Antituberculosis Medical Drugs in Tanzania (Project TuberXpert): Protocol for an Algorithm' Development and Implementation
Yann Thoma, Annie E Cathignol, Yuan J Pétermann, et al.
Therapeutic Drug Monitoring
|
March 19, 2013
Relationship of CYP2D6, CYP3A, POR, and ABCB1 genotypes with galantamine plasma concentrations
Muriel Noetzli, Monia Guidi, Karsten Ebbing, et al.
Pharmaceutics
|
April 28, 2023
Precision Oncology by Point-of-Care Therapeutic Drug Monitoring and Dosage Adjustment of Conventional Cytotoxic Chemotherapies: A Perspective
Myriam Briki, Pascal André, Yann Thoma, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
January 16, 2026
Pharmacometric-Based Evaluation of Salmeterol and Its Metabolite α-Hydroxysalmeterol in Plasma and Urine: Practical Implications for Doping Control
Paul Thoueille, Anne Danion, Morten Hostrup, et al.
Page
of 11